HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In-Su Kim Selected Research

Neoplasms (Cancer)

12/2020Therapeutic Potential of Lindera obtusiloba: Focus on Antioxidative and Pharmacological Properties.
1/2020Exogenous Ganglioside GT1b Enhances Porcine Oocyte Maturation, Including the Cumulus Cell Expansion and Activation of EGFR and ERK1/2 Signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


In-Su Kim Research Topics

Disease

14Neuroinflammatory Diseases
06/2023 - 01/2012
14Parkinson Disease (Parkinson's Disease)
10/2022 - 04/2011
8Neurodegenerative Diseases (Neurodegenerative Disease)
06/2023 - 01/2018
6Cognitive Dysfunction
05/2021 - 01/2012
5Nervous System Diseases (Neurological Disorders)
06/2023 - 01/2018
5Inflammation (Inflammations)
12/2020 - 08/2012
5Insulin Resistance
01/2014 - 01/2010
4Neuroblastoma
04/2022 - 11/2016
3Type 2 Diabetes Mellitus (MODY)
08/2012 - 01/2011
2B-Cell Lymphoma (Lymphoma, B Cell)
04/2022 - 10/2020
2Epilepsy (Aura)
01/2022 - 01/2019
2Neoplasms (Cancer)
12/2020 - 01/2020
2Gliosis
08/2013 - 01/2013
2Carcinoma (Carcinomatosis)
08/2012 - 01/2010
2Diabetes Mellitus
08/2012 - 01/2010
1Obesity
06/2023
1Memory Disorders (Memory Loss)
09/2022
1Alzheimer Disease (Alzheimer's Disease)
01/2022
1Mitochondrial Diseases (Mitochondrial Disease)
01/2022
1Amnesia (Dissociative Amnesia)
05/2021
1Hypersensitivity (Allergy)
12/2020
1Wounds and Injuries (Trauma)
01/2019
1Diabetic Neuropathies (Diabetic Neuropathy)
01/2019
1Stroke (Strokes)
01/2019
1Brain Diseases (Brain Disorder)
01/2018
1Infections
01/2018
1Cicatrix (Scar)
01/2017
1Central Nervous System Diseases (CNS Diseases)
10/2015
1Hypoxia (Hypoxemia)
06/2015
1Pain (Aches)
04/2015
1Carotid Artery Injuries
12/2014
1Hyperglycemia
01/2014
1Hypokinesia (Bradykinesia)
01/2013
1Atherosclerosis
02/2012

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
06/2023 - 11/2016
51- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
04/2021 - 01/2013
5CytokinesIBA
01/2021 - 01/2012
5Glucose (Dextrose)FDA LinkGeneric
01/2014 - 01/2010
4AntioxidantsIBA
06/2023 - 01/2012
4Neuroprotective AgentsIBA
06/2023 - 01/2013
41-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA
04/2022 - 01/2013
4asaroneIBA
01/2022 - 01/2012
3Scopolamine (Hyoscine)FDA Link
09/2022 - 01/2018
3NF-kappa B (NF-kB)IBA
01/2017 - 01/2012
3Insulin (Novolin)FDA Link
08/2012 - 01/2010
2Hypoglycemic Agents (Hypoglycemics)IBA
06/2023 - 08/2012
2SynucleinsIBA
10/2022 - 01/2022
2dioscinIBA
09/2022 - 04/2022
2LipopolysaccharidesIBA
05/2021 - 04/2011
2ErbB Receptors (EGF Receptor)IBA
01/2020 - 02/2017
2Cholinergic Agents (Cholinergics)IBA
01/2018 - 01/2012
2Transcription Factors (Transcription Factor)IBA
06/2015 - 12/2012
13-azido-2,7-naphthalene disulfonateIBA
06/2023
1Antihypertensive Agents (Antihypertensives)IBA
06/2023
1Caspase 3 (Caspase-3)IBA
04/2022
1Nerve Growth Factors (Neurotrophins)IBA
01/2022
1CaspasesIBA
04/2021
14-trifluoromethylsalicylic acid (HTB)IBA
11/2020
1AnhydridesIBA
11/2020
1Messenger RNA (mRNA)IBA
10/2020
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
10/2020
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
10/2020
1InflammasomesIBA
01/2020
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2020
1trisialoganglioside GT1IBA
01/2020
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
10/2019
1QuercetinIBA
10/2019
1GTP-Binding Proteins (G-Protein)IBA
10/2019
1TaurineFDA Link
01/2019
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2019
1PolyphenolsIBA
01/2019
1ginsenoside M1IBA
09/2018
1GinsenosidesIBA
09/2018
1Liposomes (Liposome)IBA
09/2018
1gintoninIBA
09/2018
1thymoquinoneIBA
01/2018
1Coloring Agents (Dyes)IBA
01/2018
1Glutamate Receptors (Glutamate Receptor)IBA
01/2018
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2018
1Retinaldehyde (Retinal)IBA
01/2017
1Small Interfering RNA (siRNA)IBA
11/2016
1ConnexinsIBA
11/2016
1Connexin 43 (Connexin43)IBA
11/2016
1Therapeutic UsesIBA
10/2015
1Oxygen (Dioxygen)IBA
06/2015
1Ethanol (Ethyl Alcohol)IBA
04/2015
1CollagenIBA
12/2014
1Adenosine Diphosphate (ADP)IBA
12/2014
1Blood Glucose (Blood Sugar)IBA
01/2014
1NeurotoxinsIBA
08/2013
1PyrrolidinesIBA
01/2013
1gastrodinIBA
01/2013
1Dopamine (Intropin)FDA LinkGeneric
01/2013
1eriodictyolIBA
08/2012
1naringeninIBA
02/2012
1Becaplermin (PDGF-BB)FDA Link
02/2012

Therapy/Procedure

5Therapeutics
04/2022 - 01/2017
2Oral Administration
11/2020 - 12/2014
2East Asian Traditional Medicine (Oriental Medicine)
04/2015 - 11/2013
1Lasers (Laser)
01/2017